Xcout Intel
Neurinnov
Neurinnov is a medical technology company based in Montpellier, France, specializing in innovation within neurostimulation. The firm has developed a versatile technology platform designed to restore human functions in individuals suffering from functional deficiencies across multiple pathologies. Through its specialized medical research, the company creates clinical value and therapeutic solutions.
Subscribe to see Neurinnov’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Neurinnov at a glance
Neurinnov is a medical devices company headquartered in France. Its most recent funding round, Grant, raised $2.5M in February 2026. Xcout tracks 6 named people at Neurinnov, including Nicolas Serandour (President and Mandataire social).
Neurinnov leadership
- Nicolas SerandourPresident and Mandataire social
- David AndreuCo-founder, CTO and General Manager
- David GuiraudCo-founder and CSO
- Geneviève BlancInvestment Director IRDI
- Lucie AyalaDirector of Capital Innovation Investments SOFILARO
- Jonathan DupontAssociate MERIEUX EQUITY PARTNERS
Neurinnov funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Grant | $2.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Neurinnov competitors
A few of Neurinnov's closest competitors — see the full list of competitors and alternatives →
Nervonik is a medical technology company headquartered in Los Angeles, California, focusing on neuromodulation devices. The company develops next-generation peripheral nerve stimulation technology engineered to integrate dynamic stimulation for high-motion activities.
Bioness Medical, Inc. is a medical technology provider headquartered in Valencia, California. Founded in 2004, the company specializes in innovative rehabilitation technologies, such as functional electrical stimulation, to help individuals with neurological conditions regain mobility and independence.
Sonomind is a medical device company specializing in non-invasive brain stimulation utilizing low-intensity focused ultrasound to treat drug-resistant conditions. The Paris-based biotech and life science startup develops novel neurostimulation therapies and recently secured funding to advance its medical technology.
Blackrock Neurotech develops innovative brain-computer interface technologies designed to restore function, communication, and movement for individuals with paralysis and neurological disorders.
Autonomix Medical, Inc. is an emerging medical device company focused on developing advanced solutions for identifying and treating various disorders impacting the peripheral nervous system. At the core of its innovation is a sophisticated technology platform that incorporates a catheter-based, microchip-enabled sensing array, engineered to precisely detect and differentiate peripheral neural signals. This Texas-based firm, headquartered in The Woodlands, was established in 2014.
TrainFES is a healthcare technology company based in Santiago, Chile, that creates wireless systems to improve the quality of life for people with spinal cord injuries or stroke complications. The company serves neurorehabilitation institutions and has achieved FDA clearance for its advanced devices.
Get Neurinnov's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Neurinnov in Xcout Intel
- 6 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access